1. Home
  2. CMND vs ORIS Comparison

CMND vs ORIS Comparison

Compare CMND & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMND
  • ORIS
  • Stock Information
  • Founded
  • CMND 2017
  • ORIS 2014
  • Country
  • CMND Canada
  • ORIS China
  • Employees
  • CMND N/A
  • ORIS N/A
  • Industry
  • CMND Biotechnology: Pharmaceutical Preparations
  • ORIS Farming/Seeds/Milling
  • Sector
  • CMND Health Care
  • ORIS Consumer Staples
  • Exchange
  • CMND Nasdaq
  • ORIS Nasdaq
  • Market Cap
  • CMND 5.3M
  • ORIS 5.3M
  • IPO Year
  • CMND N/A
  • ORIS 2024
  • Fundamental
  • Price
  • CMND $1.03
  • ORIS $0.16
  • Analyst Decision
  • CMND
  • ORIS
  • Analyst Count
  • CMND 0
  • ORIS 0
  • Target Price
  • CMND N/A
  • ORIS N/A
  • AVG Volume (30 Days)
  • CMND 34.4K
  • ORIS 17.4M
  • Earning Date
  • CMND 09-11-2025
  • ORIS 01-01-0001
  • Dividend Yield
  • CMND N/A
  • ORIS N/A
  • EPS Growth
  • CMND N/A
  • ORIS N/A
  • EPS
  • CMND N/A
  • ORIS 0.17
  • Revenue
  • CMND N/A
  • ORIS $15,014,000.00
  • Revenue This Year
  • CMND N/A
  • ORIS N/A
  • Revenue Next Year
  • CMND N/A
  • ORIS N/A
  • P/E Ratio
  • CMND N/A
  • ORIS $0.83
  • Revenue Growth
  • CMND N/A
  • ORIS N/A
  • 52 Week Low
  • CMND $0.80
  • ORIS $0.08
  • 52 Week High
  • CMND $2.18
  • ORIS $56.01
  • Technical
  • Relative Strength Index (RSI)
  • CMND 52.16
  • ORIS 52.55
  • Support Level
  • CMND $0.99
  • ORIS $0.13
  • Resistance Level
  • CMND $1.04
  • ORIS $0.20
  • Average True Range (ATR)
  • CMND 0.04
  • ORIS 0.02
  • MACD
  • CMND -0.00
  • ORIS 0.01
  • Stochastic Oscillator
  • CMND 43.11
  • ORIS 57.78

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

Share on Social Networks: